Five years ago, the concept of oligonucleotide therapeutics was barely a dream. Now, new technologies and industry awareness have transformed the landscape to bring these novel modalities to market. Join this session to learn how today's hottest tools—AI and machine learning—are driving on-demand gene therapies into the clinic. Hear how innovative business solutions plus the synbio mindset are working to make a faster difference for patients and their families.